Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-219016
Filing Date
2025-09-26
Accepted
2025-09-26 09:41:22
Documents
5
Period of Report
2025-09-26

Document Format Files

Seq Description Document Type Size
1 6-K d29732d6k.htm 6-K 8694
2 EX-99.1 d29732dex991.htm EX-99.1 15937
3 EX-99.2 d29732dex992.htm EX-99.2 15467
4 GRAPHIC g29732g0926035103705.jpg GRAPHIC 2601
5 GRAPHIC g29732g39w89.jpg GRAPHIC 8587
  Complete submission text file 0001193125-25-219016.txt   51610
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251345809
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)